Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.30.2 (
endonuclease
)
18,621
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Double-strand breaks (DSBs) trigger rapid and transient transcription pause to prevent collisions between repair and transcription machineries at damage sites. Little is known about the mechanisms that ensure transcriptional block after DNA damage. Here, we reveal a novel role of the negative elongation factor NELF in blocking transcription activity nearby DSBs. We show that
NELF-E
and NELF-A are rapidly recruited to DSB sites. Furthermore,
NELF-E
recruitment and its repressive activity are both required for switching off transcription at DSBs. Remarkably, using I-SceI
endonuclease
and CRISPR-Cas9 systems, we observe that
NELF-E
is preferentially recruited, in a PARP1-dependent manner, to DSBs induced upstream of transcriptionally active rather than inactive genes. Moreover, the presence of RNA polymerase II is a prerequisite for the preferential recruitment of
NELF-E
to DNA break sites. Additionally, we demonstrate that
NELF-E
is required for intact repair of DSBs. Altogether, our data identify the NELF complex as a new component in the DNA damage response.
...
PMID:NELF-E is recruited to DNA double-strand break sites to promote transcriptional repression and repair. 2833 77